Humana
HUM Β· Managed Health Care
$422.07
0.3%Molina Healthcare
MOH Β· Managed Health Care
$209.15
3.5%The short version
- Humana is the larger business, with $129.7B of revenue in fiscal 2025 against $45.4B for Molina Healthcare, about 2.9 times as much.
- Molina Healthcare grew revenue faster (11.8%, against 10.1%).
- Humana turned more of its sales into free cash flow (0.3% FCF margin, against β1.4% FCF margin).
| Latest fiscal year | HUM Β· FY25 | MOH Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $50.9B | $10.8B |
| Revenue | $129.7B | $45.4B |
| Free cash flow | $375M | β$636M |
| Net income | $1.2B | $472M |
| Growth | ||
| Revenue growth | 10.1% | 11.8% |
| 5-year growth | 10.9% | 18.5% |
| Share count change | β0.0% | β8.3% |
| Profitability | ||
| Gross margin | β | β |
| Operating margin | 2.1% | 1.7% |
| Net margin | 0.9% | 1.0% |
| FCF margin | 0.3% | β1.4% |
| Return on capital | 25.7% | β |
| Return on equity | 7.0% | 11.0% |
| Balance sheet | ||
| Net debt | β$7.5B | β$4.3B |
| Net debt / EBITDA | β2.2x | β4.4x |
| Dividends and buybacks | $581M | $1.0B |
| Valuation & quality | ||
| P/E | 45.0x | β |
| Piotroski F-score | 5 | 4 |
FY16
HUM $54.4B
MOH $17.8B
FY17
HUM $53.8B
MOH $19.9B
FY18
HUM $56.9B
MOH $18.9B
FY19
HUM $64.9B
MOH $16.8B
FY20
HUM $77.2B
MOH $19.4B
FY21
HUM $83.1B
MOH $27.8B
FY22
HUM $92.9B
MOH $32.0B
FY23
HUM $106.4B
MOH $34.1B
FY24
HUM $117.8B
MOH $40.7B
FY25
HUM $129.7B
MOH $45.4B
HUM
MOH
FY16
HUM 3.2%
MOH 1.7%
FY17
HUM 7.9%
MOH β2.8%
FY18
HUM 5.5%
MOH 6.0%
FY19
HUM 4.9%
MOH 6.2%
FY20
HUM 6.5%
MOH 5.6%
FY21
HUM 3.8%
MOH 3.7%
FY22
HUM 4.1%
MOH 3.7%
FY23
HUM 3.8%
MOH 4.6%
FY24
HUM 2.2%
MOH 4.2%
FY25
HUM 2.1%
MOH 1.7%
HUM
MOH
FY16
HUM $1.4B
MOH $497M
FY17
HUM $3.5B
MOH $718M
FY18
HUM $1.6B
MOH β$344M
FY19
HUM $4.5B
MOH $377M
FY20
HUM $4.7B
MOH $1.8B
FY21
HUM $920M
MOH $2.0B
FY22
HUM $3.5B
MOH $682M
FY23
HUM $3.0B
MOH $1.6B
FY24
HUM $2.4B
MOH $544M
FY25
HUM $375M
MOH β$636M
HUM
MOH
FY16
HUM 22.0%
MOH β
FY17
HUM β
MOH β
FY18
HUM β
MOH β
FY19
HUM β
MOH β
FY20
HUM β
MOH β
FY21
HUM 42.8%
MOH β
FY22
HUM 38.5%
MOH β
FY23
HUM 56.3%
MOH β
FY24
HUM 30.9%
MOH β
FY25
HUM 25.7%
MOH β
HUM
MOH
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.